BTIG Starts Heartware Int'l (HTWR) at Neutral (Earlier)

February 20, 2014 10:58 AM EST Send to a Friend
Get Alerts HTWR Hot Sheet
Price: $78.31 --0%

Rating Summary:
    12 Buy, 6 Hold, 5 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 32 | Down: 14 | New: 26
Trade HTWR Now!
Join SI Premium – FREE
BTIG initiated coverage on Heartware Int'l (NASDAQ: HTWR) with a Neutral rating.

Analyst Sean Lavin said, "Taking U.S. share has proven more difficult than we initially thought. It seems a DT label, especially in light of the recent NCD change and 4Q miss will be more important to taking U.S. share than we would have predicted a year ago."

"We feel HTWR's pipeline is robust, but risky. HTWR is working on several products: MVAD, SYNERGY Surgical and Endovascular Systems, and Longhorn. MVAD is the most important. We believe MVAD offers greater technical advances than THOR’s HMIII but also greater risk as the devices are brought to market," he added.

For an analyst ratings summary and ratings history on Heartware Int'l click here. For more ratings news on Heartware Int'l click here.

Shares of Heartware Int'l closed at $101.29 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View, New Coverage

Add Your Comment